Literature DB >> 31313473

Characterising 'bounce-back' readmissions after radical cystectomy.

Peter S Kirk1, Ted A Skolarus1,2, Bruce L Jacobs3, Yongmei Qin1, Benjamin Li1, Michael Sessine1, Xiang Liu4, Kevin Zhu1, Scott M Gilbert5, Brent K Hollenbeck1, Ken Urish6, Jonathan Helm7, Mariel S Lavieri4, Tudor Borza8.   

Abstract

OBJECTIVE: To examine predictors of early readmissions after radical cystectomy (RC). Factors associated with preventable readmissions may be most evident in readmissions that occur within 3 days of discharge, commonly termed 'bounce-back' readmissions, and identifying such factors may inform efforts to reduce surgical readmissions. PATIENTS AND METHODS: We utilised the Healthcare Cost and Utilization Project's State Inpatient Databases to examine 1867 patients undergoing RC in 2009 and 2010, and identified all patients readmitted within 30 days of discharge. We assessed differences between patients experiencing bounce-back readmission compared to those readmitted 8-30 days after discharge using logistic regression models and also calculated abbreviated LACE scores to assess the utility of common readmissions risk stratification algorithms.
RESULTS: The 30-day and bounce-back readmission rates were 28.4% and 5.6%, respectively. Although no patient or index hospitalisation characteristics were significantly associated with bounce-back readmissions in adjusted analyses, bounce-back patients did have higher rates of gastrointestinal (14.3% vs 6.7%, P = 0.02) and wound (9.5% vs 3.0%, P < 0.01) diagnoses, as well as increased index and readmission length of stay (5 vs 4 days, P = 0.01). Overall, the median abbreviated LACE score was 7, which fell into the moderate readmission risk category, and no difference was observed between readmitted and non-readmitted patients.
CONCLUSION: One in five readmissions after RC occurs within 3 days of initial discharge, probably due to factors present at discharge. However, sociodemographic and clinical factors, as well as traditional readmission risk tools were not predictive of this bounce-back. Effective strategies to reduce bounce-back readmission must identify actionable clinical factors prior to discharge.
© 2019 The Authors BJU International © 2019 BJU International Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  #BladderCancer; #blcsm; Cystectomy; hospital readmissions; postoperative complications

Mesh:

Year:  2019        PMID: 31313473      PMCID: PMC6879782          DOI: 10.1111/bju.14874

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  30 in total

1.  Few modifiable factors predict readmission following radical cystectomy.

Authors:  Brian J Minnillo; Matthew J Maurice; Nicholas Schiltz; Aiswarya C Pillai; Siran M Koroukian; Firouz Daneshgari; Sim P Kim; Robert Abouassaly
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

2.  No Differences in Population-based Readmissions After Open and Robotic-assisted Radical Cystectomy: Implications for Post-discharge Care.

Authors:  Tudor Borza; Bruce L Jacobs; Jeffrey S Montgomery; Alon Z Weizer; Todd M Morgan; Khaled S Hafez; Cheryl T Lee; Benjamin Y Li; Hye Sung Min; Chang He; Scott M Gilbert; Jonathan E Helm; Mariel S Lavieri; Brent K Hollenbeck; Ted A Skolarus
Journal:  Urology       Date:  2017-03-04       Impact factor: 2.649

3.  Readmission following primary surgery for larynx and oropharynx cancer in the elderly.

Authors:  Hamad Chaudhary; C Matthew Stewart; Kimberly Webster; Robert J Herbert; Kevin D Frick; David W Eisele; Christine G Gourin
Journal:  Laryngoscope       Date:  2016-09-23       Impact factor: 3.325

4.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

Review 5.  Transitional care interventions to prevent readmissions for persons with heart failure: a systematic review and meta-analysis.

Authors:  Cynthia Feltner; Christine D Jones; Crystal W Cené; Zhi-Jie Zheng; Carla A Sueta; Emmanuel J L Coker-Schwimmer; Marina Arvanitis; Kathleen N Lohr; Jennifer C Middleton; Daniel E Jonas
Journal:  Ann Intern Med       Date:  2014-06-03       Impact factor: 25.391

6.  Understanding hospital readmission intensity after radical cystectomy.

Authors:  Ted A Skolarus; Bruce L Jacobs; Florian R Schroeck; Chang He; Alexander M Helfand; Jonathan Helm; Michael Hu; Mariel Lavieri; Brent K Hollenbeck
Journal:  J Urol       Date:  2014-11-04       Impact factor: 7.450

7.  The effect of neoadjuvant chemotherapy on perioperative outcomes in patients who have bladder cancer treated with radical cystectomy: a population-based study.

Authors:  Giorgio Gandaglia; Ioana Popa; Firas Abdollah; Jonas Schiffmann; Shahrokh F Shariat; Alberto Briganti; Francesco Montorsi; Quoc-Dien Trinh; Pierre I Karakiewicz; Maxine Sun
Journal:  Eur Urol       Date:  2014-01-24       Impact factor: 20.096

8.  Derivation and validation of an index to predict early death or unplanned readmission after discharge from hospital to the community.

Authors:  Carl van Walraven; Irfan A Dhalla; Chaim Bell; Edward Etchells; Ian G Stiell; Kelly Zarnke; Peter C Austin; Alan J Forster
Journal:  CMAJ       Date:  2010-03-01       Impact factor: 8.262

9.  Characterization of Readmission by Day of Rehospitalization After Colorectal Surgery.

Authors:  Ahmed M Al-Mazrou; Kunal Suradkar; Christine M Mauro; Ravi P Kiran
Journal:  Dis Colon Rectum       Date:  2017-02       Impact factor: 4.585

10.  Determinants of preventable readmissions in the United States: a systematic review.

Authors:  Joshua R Vest; Larry D Gamm; Brock A Oxford; Martha I Gonzalez; Kevin M Slawson
Journal:  Implement Sci       Date:  2010-11-17       Impact factor: 7.327

View more
  1 in total

1.  Randomized Controlled Trial of Laparoscopic versus Open Radical Cystectomy in a Laparoscopic Naïve Center.

Authors:  Waleed Mohamed Fadlalla; Ayman Hanafy; Mahmoud Abdelhakim; Hatem Aboulkassem; El Sayed Ashraf; Ahmed Abdelbary
Journal:  Adv Urol       Date:  2021-07-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.